23 Jun Madison stem cell company expands research with National Eye Institute contract
Madison-based Cellular Dynamics International will expand its stem cell-based research into blindness-causing eye disease through a collaborative project with the National Eye Institute at the National Institutes of Health.
The agreement means CDI will provide manufactured cells with the potential for transplantation to treat retinal degenerative diseases, such as macular degeneration, the leading cause of blindness. The Eye Institute will conduct experiments, and the two will perform studies and co-examine results.
CDI and the Eye Institute have already worked together on a related contract, started in 2014, which converts blood and tissue from patients into stem cells. The long-term goal is regeneration by putting reprogrammed, manufactured cells back into the patients.
Sorry, the comment form is closed at this time.